Drug · DIN 01966162
NORFLEX
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 30, 2014; first marketed December 31, 1961.
- Drug Identification Number (DIN)
- 01966162
- Company (DIN owner)
- Valeant Canada LpLaval, Quebec, Canada
- Schedule
- Ethical
- Dosage form
- Liquid
- Route
- Intravenous; Intramuscular
- Therapeutic class (ATC)
- Orphenadrine (citrate) M03BC01
- Class
- Human
- Record last updated
- June 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ORPHENADRINE CITRATE | 30 MG | ML |
Other DINs named NORFLEX
- DIN 01966154 · Cancelled Post Market